Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.43 |
| ▸ | NPY4R | P50391 | 7/20 | 0.40 |
| ▸ | NPY1R | P25929 | 4/20 | 0.40 |
| ▸ | NPY2R | P49146 | 4/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.38 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.38 |
| ▸ | GSTK1 | Q9Y2Q3 | 1/20 | 0.38 |
| ▸ | FNTA | P49354 | 2/20 | 0.38 |
| ▸ | FNTB | P49356 | 2/20 | 0.38 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | OTC | P00480 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19139 | 1.00 | NOD1 (0.43) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL9440021 | 1.00 | NOD1 (0.43) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29647707 | 1.00 | NOD1 (0.43) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL13123122 | 1.00 | NOD1 (0.43) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL10421871 | 1.00 | NOD1 (0.43) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| Hydrochloric Acid SCHEMBL9192751 | 0.99 | NOD1 (0.42) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| Hydrochloric Acid SCHEMBL9192761 | 0.99 | NOD1 (0.42) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30639759 | 0.96 | NOD1 (0.45) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL29750820 | 0.94 | NPY4R (0.42) | NOD1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL30867028 | 0.94 | NPY4R (0.42) | NOD1NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092254-A1 | FULLY DEFINED MATRICES FOR ORGANOID CULTURE | INSOMA BIO INC (US) | 2026-04-02 | — | — | US | claimed |
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-03-10 | — | — | US | claimed |
| US-12540300-B2 | Bioreactor and method for cultivating biological cells on substrate filaments | FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 2026-02-03 | — | — | US | claimed |
| EP-4684872-A1 | DEVICE AND METHOD FOR WATER-IN-AIR GENERATION OF DROPLETS | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2026-01-28 | — | — | EP | claimed |
| EP-4680939-A1 | SAMPLE MOUNT FOR A MICROSCOPE | European Molecular Biology Laboratory (DE) | 2026-01-21 | — | — | EP | claimed |
| US-20260009004-A1 | SYSTEMS AND METHODS FABRICATING A MICROCHANNEL VASCULAR NETWORK DEVICE AND SEEDING A MICROCHANNEL | 3D BIOLABS LLC (US) | 2026-01-08 | — | — | US | claimed |
| WO-2025245374-A1 | PEPTIDIC CHIMERIC ANTIGEN RECEPTOR EFFECTOR CELL ADAPTERS AND USES THEREOF | THE NEMOURS FOUNDATION (US) | 2025-11-27 | — | — | WO | claimed |
| US-12466814-B2 | Sterically shielded heptamethine cyanine dyes | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2025-11-11 | — | — | US | claimed |
| WO-2025224047-A1 | FUNCTIONALIZATION OF PEGYLATED SURFACE | STICHTING RADBOUD UNIVERSITEIT (NL) | 2025-10-30 | — | — | WO | claimed |
| US-20250325722-A1 | Method of Deodorizing, Antibacterial and Decontamination Using Plasmonic Photocatalyst and Method for Treating Cancer | UNIV NAT TSING HUA (TW) | 2025-10-23 | — | — | US | claimed |
| CN-103893128-A | Tumor-therapy composite nano material and preparation method thereof | NINGBO INST MATERIALS TECHNOLOGY & ENG CAS | 2014-07-02 | — | — | CN | claimed |
| CN-103849567-A | Bioreactor for inducing three-dimensional directional differentiation in vitro of stem cells by virtue of non-contact coculture | DALIAN CHEMICAL PHYSICS INST | 2014-06-11 | — | — | CN | claimed |
| CN-103849594-A | In-vitro three-dimensional culture method for palatal organ | UNIV DALIAN MEDICAL | 2014-06-11 | — | — | CN | claimed |
| CN-103849593-A | 3D (Three-Dimensional) co-culture method for magnetic separated cells | DALIAN CHEMICAL PHYSICS INST | 2014-06-11 | — | — | CN | claimed |
| WO-2013172616-A1 | PREPARATION OF TECHNETIUM-99M TRICARBONYL LABELED GLYCINE MONOMER OR OLIGOMER CONTAINING PROBES THAT HAVE BIOMOLECULES AND ITS APPLICATION AS IMAGING COMPLEX-COMPOSITION | KOREA ATOMIC ENERGY RESEARCH INSTITUTE (KR) | 2013-11-21 | — | — | WO | claimed |
| CN-103386114-A | Application of artificial platelet PLAG-PEG-RCD to preparing systemic nanometer styptic for veins | INST TRANSFUSION MEDICINE ACADEMY MILITARY MEDICAL SCIENCES | 2013-11-13 | — | — | CN | claimed |
| CN-102614532-B | Multifunctional tumor imaging agent, preparation method and application | UNIV JIANGSU | 2013-07-17 | — | — | CN | claimed |
| CN-103103157-A | Non-contact three-dimensional co-culture method for cells | DALIAN CHEMICAL PHYSICS INST | 2013-05-15 | — | — | CN | claimed |
| CN-102614532-A | Multifunctional tumor imaging agent, preparation method and application | UNIV JIANGSU | 2012-08-01 | — | — | CN | claimed |
| EP-1336602-A1 | Nitrate prodrugs able to release nitric oxide in a controlled and selective way and their use for prevention and treatment of inflammatory, ischemic and proliferative diseases | Scaramuzzino, Giovanni (IT) | 2003-08-20 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12466814-B2 | Sterically shielded heptamethine cyanine dyes | FCGR3B, MYADM, FCGR2A | NOD1 1521/4885NPY4R 839/4885NPY1R 346/4885 |
| US-12540300-B2 | Bioreactor and method for cultivating biological cells on substrate filaments | FGB, ACTB, ECPAS | NOD1 3280/4885NPY4R 3806/4885NPY1R 3290/4885 |
| US-20260092254-A1 | FULLY DEFINED MATRICES FOR ORGANOID CULTURE | IAPP, ADM2, ARG1 | NOD1 2495/4885NPY4R 702/4885NPY1R 1033/4885 |
| US-20250325722-A1 | Method of Deodorizing, Antibacterial and Decontamination Using Plasmonic Photocatalyst and Method for Treating Cancer | DDO, LPO, DDT | NOD1 3275/4885NPY4R 4554/4885NPY1R 4777/4885 |
| US-20260009004-A1 | SYSTEMS AND METHODS FABRICATING A MICROCHANNEL VASCULAR NETWORK DEVICE AND SEEDING A MICROCHANNEL | KDR, FLT4, FLT1 | NOD1 1256/4885NPY4R 2197/4885NPY1R 2095/4885 |
| US-12569439-B2 | Bottom-up assembly of synthetic extracellular vesicles | EXOSC10, PLTP, EXOSC9 | NOD1 2020/4885NPY4R 3143/4885NPY1R 2409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.